The best providers are not just focused on getting you on semaglutide
EMPA-REG not only showed that empagliflozin was safe, but it also showed a stunning, and largely unexpected, reduction in CV mortality, heart failure admissions, and total mortality (Figure 3)
The details of the data have been published elsewhere, and the healthcare outcomes derived from these data were compared with other data sets for validity and consistency
It combines two mechanisms to enhance appetite regulation and improve how the body processes nutrients, making it particularly effective for individuals with stubborn weight or complex metabolic challenges
It increases insulin secretion when glucose is high, reduces glucagon release from the liver, and slows gastric emptying to prevent rapid post-meal blood sugar spikes